Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04604899 · ClinicalTrials.gov registry record · Phase 2

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

A Phase 2 study of Retinitis Pigmentosa, sponsored by jCyte.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
3
Study locations

NCT04604899 is a Phase 2 study of Retinitis Pigmentosa that has completed, run by jCyte. The registered enrollment target is 30 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04604899, a Phase 2 study of Retinitis Pigmentosa, has completed, sponsored by jCyte.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
3
Study locations

Study Summary

The primary objective of the study is to assess the safety of repeat injection of human retinal progenitor cells (jCell) in adult subjects with RP that have previously been treated with jCell.

Conditions Studied

Retinitis Pigmentosa

Interventions

  • BIOLOGICAL human retinal progenitor cells

Study Locations (3)

California

  • Gavin Herbert Eye Inst, Univ Cal Irvine - Irvine
  • Retina-Vitreous Associates Medical Group - Los Angeles

Massachusetts

  • Ophthalmic Consultants of Boston - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-12-01
Est. Completion 2022-03-22
Phase Phase 2

Sponsor

jCyte

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04604899

The ClinicalTrials.gov registry entry for NCT04604899 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (89% lower). The listed sponsor is jCyte, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 1 intervention - of which human retinal progenitor cells is the first listed.

NCT04604899 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04604899 about?

NCT04604899 is a clinical study titled "Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa". The primary objective of the study is to assess the safety of repeat injection of human retinal progenitor cells (jCell) in adult subjects with RP that have previously been treated with jCell.

What is the current status of trial NCT04604899?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2020-12-01. Estimated completion is 2022-03-22.

What conditions does trial NCT04604899 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

What interventions are being tested in trial NCT04604899?

The interventions under investigation include: human retinal progenitor cells (BIOLOGICAL).

Who is sponsoring clinical trial NCT04604899?

This trial is sponsored by jCyte, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04604899 being conducted?

This trial has 3 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Retinitis Pigmentosa

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.